[Multicentric clinical trial of a new combination of a broad spectrum antimycotic and a dermocorticoid (author's transl)].
After having reviewed the conditions of use of an antimycotic-corticoid combination, the authors are reporting their clinical results on 183 patients of a new drug combining econazole and triamcinolon. This clinical trial demonstrates that the own activity of each component of the combination is entirely maintained, and that the new combination shows an original interest in the treatment of all inflammatory dermatomycoses, as well as inflammatory supra-infected dermatoses.
D000287:Administration, Topical; D000328:Adult; D002675:Child, Preschool; D003881:Dermatomycoses / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D004464:Econazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007223:Infant; D009824:Ointments; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D007093:Imidazoles; D009824:Ointments; D004464:Econazole; D014222:Triamcinolone Acetonide
Etude thérapeutique multicentrique d'une nouvelle association d'un antifongique à large spectre et d'un corticoïde.